Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
9,469 total articles
Humana looks attractively priced after a sharp sector-driven selloff. The stock trades near $187 with a P/E around 17.8 and a market cap near $22.6B, while the business maintains strong Medicare Advantage enrollment and a growing CenterWell services unit. This trade targets a patient long-term recovery over 180 trading days with a clear entry, stop…
Broadridge (BR) has been punished alongside high-valuation SaaS names despite steady recurring revenue, solid free cash flow of $1.3186B, and strategic M&A that expands its trading footprint. We view the recent weakness as a buying opportunity: entry at $186.48, stop loss $173.00, and target $215.00 for a mid-term swing (45 trading days) with a fav…
Nike is trading at $60.995 after a painful multi-year reset. The 'win-now' push from management — product innovation, discipline in wholesale, and margin repair — creates a tactical long opportunity. Entry $60.995, target $78.00, stop $55.00, horizon: long term (180 trading days).
FS KKR Capital (FSK) trades near its 52-week low at $10.85 with a roughly 26% indicated yield, sub-1.0 P/B, and a P/E near 11. The shares are deeply oversold technically and carry elevated short interest — a setup that offers a high margin of safety if distributions hold. This trade idea lays out an entry at $10.85, a stop at $9.50, and a target of…
Ondas (ONDS) has transformed from a sub-$1 name last year into a $4.8B market-cap drone and ISR contender thanks to a string of defense contracts, an acquisition, and a swollen cash balance. The set-up is binary: continued contract execution and integration could push the stock back toward analyst targets, but valuation and execution risk remain el…
Nano Labs (NA) is a sub-$100M microcap that has shifted toward a crypto-reserve strategy while retaining semiconductor IP. The move reduced operating expenses and produced a cleaner loss profile, and management has been buying stock. At a market cap of roughly $70.5M and a float of ~11.5M shares, the company’s >128,000 BNB reserve could materially …
Teleflex ($TFX) is trading near $122.93 after a run-up that has pushed momentum indicators into bullish territory. The business still shows negative EPS but solid free cash flow, a modest leverage profile, and exposure to several end-markets that are growing. This trade idea lays out a mid-term (45 trading days) long with a clear entry, stop and ta…
Lincoln National (LNC) looks attractive as a mid-term trade. The stock trades at a low P/E (~5.9) and P/B (~0.66), yields roughly 5.25%, and sits well below its 50-day and 20-day averages. While private credit exposure is a known industry vulnerability, Lincoln's diversified annuities and group protection franchises, combined with an enterprise val…
Nano Labs has shifted from fabless chip development toward building crypto reserves, accumulating 128,000 BNB, cutting operating costs and shrinking revenues. At a $70.5M market cap and a share price near $2.99, this is a high-risk, high-reward swing trade that stakes on asset revaluation and improved execution over the next 45 trading days.
Blackstone (BX) has traded down sharply from its 52-week high while cash flow, ROE and a healthy dividend support a tactical long. We upgrade to a buy for a mid-term swing (45 trading days) based on attractive free cash flow yield, deep pullback toward the 52-week low, and oversold technicals. Entry $115.31, target $150.00, stop $100.00. Risk: priv…
Xometry (XMTR) has seen its shares pull back sharply from the 52-week high, but core fundamentals remain intact: accelerating marketplace revenue, strengthened profitability metrics, and a cleaned-up balance sheet after a $250M convertible note refinancing. This trade idea targets a mid-term rebound to $55 while protecting capital with a $36 stop.
H&R Block is trading near $31, yielding roughly 5.2% and buying back stock aggressively while generating >$500M in free cash flow. At ~6-7x reported EPS and an enterprise value to EBITDA near 6.4, the shares look priced for conservatism; this trade targets a re-rating and seasonal improvement into tax season with an entry at $31.00, stop at $28.00 …
Occidental (OXY) has delivered on guidance: higher production, Q4 outperformance, meaningful free cash flow and a decisive asset sale to cut debt. Those are real improvements, but the stock now trades near its 52-week high on a rally tied to a spike in oil from geopolitical shocks. With valuation elevated, technicals overheated, and upside tied to …
GPGI trades at $22.54 with a $6.52B market cap, a dividend yield of ~1.11% and rising institutional interest after a recent rebrand. The business combines metal payment cards with Arculus digital-asset authentication and services that can drive recurring revenue. Management is prioritizing debt paydown and accretive M&A, which gives upside optional…
Expedia (EXPE) is trading at a low multiple of free cash flow, generating meaningful shareholder returns via buybacks and a growing dividend, and showing resilient top-line growth. Short-term sentiment is shaken by AI headlines, but the balance sheet, cash generation, and valuation give a favorable risk-reward. I present a concrete long trade with …
Constellation Software's market narrative - steady tuck-in M&A, high-margin vertical software businesses and reliable earnings - has deservedly earned premium multiples. But with a $39.8B market cap, a P/E near 59 and P/B above 11, investors are paying up for continued outsized deployment and returns. Rising short interest, weakening technicals ver…
Accenture (ACN) has pulled back to the low $200s after a period of AI-related volatility. With a market cap near $126.7B, P/E ~17, EV/EBITDA ~9.6 and $11.5B of free cash flow, the stock looks like a rare valuation entry for long-term-oriented bottom-fishers. This trade idea sets a concrete entry at $200.00, a protective stop at $185.00, and a prima…
Solventum has signaled incremental operational improvements, but the cadence is slow and capital needs remain a live risk. For patient, size-conscious traders, a measured long with a clear stop and a 180-trading-day horizon offers a defined risk-reward: capture steady operational recovery while limiting downside exposure if liquidity or execution f…
Exxon Mobil is a high-quality cash generator that benefits from higher oil prices, but geopolitical volatility around Iran is driving an outsized short-term premium into equities. I agree with a quant-style 'Hold' while uncertainty around the Strait of Hormuz persists. For traders who want a stab at upside, a small, mid-term swing long on a discipl…
Pan American Silver (PAAS) is the most direct large-cap way to play a structurally tight silver market. The company combines meaningful silver exposure, low net leverage, and a multi-mine footprint. Technicals show momentum after a big move in the metal; we lay out an actionable long trade with entry, stop and a 180-trading-day target that reflects…
Coherent (COHR) ripped higher after news of an Nvidia partnership and a strong Q2 beat. Fundamentals show accelerating demand in data center optics, recent bookings strength and healthy balance-sheet metrics. The stock is extended but momentum and near-term catalysts justify a mid-term swing buy at $301.83 with a $350 target and a $268 stop.
V2X looks positioned to benefit from rising defense and critical-infrastructure spending on resilient vehicle-to-everything communications and rugged edge compute. With public financial disclosures thin, this is a catalyst-driven swing trade: enter at $6.50, stop at $4.50, target $10.00 over a mid-term window (45 trading days), balanced for asymmet…
Criteo (CRTO) shows softer growth headwinds across ad demand, but the stock is priced like a distressed business despite an enterprise value of $583M, minimal leverage and $159.5M in trailing free cash flow. For traders who respect fundamentals and want a defined-risk value entry, a mid-term long swing (45 trading days) into $18.30 with a $15.50 st…
Compugen's apparent win on non-dilutive funding for rilvegostomig plus advancement of GS-0321 lifts a thinly traded biotech with a $211M market cap. Momentum is real today, but the setup is still binary. This trade targets a mid-term 45-trading-day move with a tight stop to manage downside while leaving room for upside on catalysts.
Thermo Fisher (TMO) looks like a tactical long after recent weakness. The stock trades near $510 with RSI under 32 and a modest MACD bullish histogram while fundamentals - $6.1B in free cash flow and a $191B market cap - support a recovery trade into reopening demand across precision medicine, CMO services and cell/gene manufacturing. Entry $510, s…
